March 2006

Comprehensive International Program of Research on AIDS (CIPRA)

According to figures released by the Joint United Nations Programme on HIV/AIDS (UNAIDS), approximately 40 million people worldwide are now living with AIDS. Global estimates for adults and children in 2005 indicate there were roughly 4.9 million new infections and 3.1 million deaths due to AIDS. Women are increasingly at great risk of infection. According to UNAIDS, almost half of adults living with HIV and AIDS toŽday are women. In addition, over the past 2 years, the number of women and girls infected with HIV has increased in every region of the world, with rates rising particularly rapidly in Eastern Europe, Asia, and Latin America. In sub-Saharan Africa, women and girls already make up almost 60 percent of adults living with HIV.

In response to these realities, the National Institute of Allergy and Infectious Diseases (NIAID) has developed a multifaceted global HIV/AIDS research agenda. The agenda builds upon the Institute's longstanding commitment to international infectious disease research by assisting countries hardest hit by the AIDS pandemic to expand their basic and clinical HIV/AIDS research capacities, enhance partnerships for public health, and foster education of scientists and clinicians.

The Comprehensive International Program of Research on AIDS (CIPRA) is a part of NIAID's HIV/AIDS global research agenda. CIPRA supports HIV/AIDS research and development efforts at organizations located in eligible resource-poor countries to develop practical, affordable, and acceptable methods to prevent and treat HIV/AIDS in adults and children.

To date, 33 CIPRA awards have been made to institutions in 24 different countries. More information about these awards may be found at www.niaid.nih.gov/daids/cipra/award-r03.htm.

At this time, due to budget constraints, the CIPRA program is not accepting Letters of Interest for new applications.

Ongoing CIPRA awards include

• R03 Planning and Organizational Grants
1. Cairo, Egypt
2. Eldoret, Kenya
3. Kuala Lumpur, Malaysia
4. Tomsk, Russia
5. Ho Chi Minh City, Vietnam
• CIPRA U01 Exploratory/Developmental Research Grants
1. Phnom Penh, Cambodia
2. Port-au-Prince, Haiti
3. Dakar, Senegal
• CIPRA U19 Multi-project Research Grants
1. Beijing, China
2. Lima, Peru
3. Bangkok, Thailand
4. Durban, South Africa
5. Johannesburg, South Africa

1. Buenos Aires, Argentina
2. Caxias do Sul, Brazil
3. Porto Alegre, Brazil
4. Rio de Janeiro, Brazil
5. Phnom Penh, Cambodia
6. Beijing, China
7. Brazzaville, Congo
8. Puerto Plata, Dominican Republic
9. Tbilisi, Georgia
10. New Delhi and Pune, India
11. Cuernavaca, Mexico
12. Lima, Peru
13. St. Petersburg, Russia
14. Moshi, Tanzania
15. Chiangmai, Thailand
16. Port of Spain, Trinidad & Tobago
17. Ho Chi Minh City, Vietnam
18. Lusaka, Zambia
19. Ndola, Zambia
20. Harare, Zimbabwe

Joan Romaine, MPH
Health Specialist
International Research Branch
Division of AIDS, NIAID
6700-B Rockledge Drive
Room 4130, MSC 7620
Bethesda, MD 20892-7620
Telephone: 301-451-2708
Fax: 301-480-4456
Email: jromaine@niaid.nih.gov

[1] CIPRA grants are awarded to institutions and investigators located in countries with a Gross National Income (GNI) per capita of less than or equal to $5,000 (according to World Bank data using the Atlas Method).

NIAID is a component of the National Institutes of Health (NIH). NIAID supports basic and applied research to prevent, diagnose, and treat infectious and immune-mediated illnesses, including HIV/AIDS and other sexually transmitted diseases, illness from potential agents of bioterrorism, tuberculosis, malaria, autoimmune disorders, asthma and allergies.

News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

Prepared by:
Office of Communications and Public Liaison
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bethesda, MD 20892

Department of Health and Human Services

National Institutes of Health (NIH) Bethesda, Maryland 20892

NIAID Home